Reuters logo
BRIEF-Prothena Corp, Prothena Biosciences enter letter agreement with Boehringer Ingelheim
April 12, 2017 / 10:50 AM / 8 months ago

BRIEF-Prothena Corp, Prothena Biosciences enter letter agreement with Boehringer Ingelheim

April 12 (Reuters) - Prothena Corporation Plc

* Prothena Corporation - on April 5, 2017, co and Prothena Biosciences entered letter agreement with Boehringer Ingelheim Biopharmaceuticals GMBH

* Prothena Corp - Boehringer Ingelheim reserved for Prothena capacity to manufacture and supply bulk drug substance of NEOD001, PRX003, possibly additional biologics

* Prothena Corp - under agreement, Prothena made commitments for purchase of products from Boehringer Ingelheim Source text: (bit.ly/2psItli) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below